Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines.

Parry AL, Clemson NA, Ellis J, Bernhard SS, Davis BG, Cameron NR.

J Am Chem Soc. 2013 Jun 26;135(25):9362-5. doi: 10.1021/ja4046857. Epub 2013 Jun 17.

2.

Multivalent Glycopolymer-Coated Gold Nanoparticles.

Richards SJ, Biggs CI, Gibson MI.

Methods Mol Biol. 2016;1367:169-79. doi: 10.1007/978-1-4939-3130-9_14.

PMID:
26537473
3.

Influenza-binding sialylated polymer coated gold nanoparticles prepared via RAFT polymerization and reductive amination.

Zhang Z, Schepens B, Nuhn L, Saelens X, Schotsaert M, Callewaert N, De Rycke R, Zhang Q, Moins S, Benali S, Mespouille L, Hoogenboom R, De Geest BG.

Chem Commun (Camb). 2016 Feb 25;52(16):3352-5. doi: 10.1039/c6cc00501b.

PMID:
26823186
4.

Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.

Brinãs RP, Sundgren A, Sahoo P, Morey S, Rittenhouse-Olson K, Wilding GE, Deng W, Barchi JJ Jr.

Bioconjug Chem. 2012 Aug 15;23(8):1513-23. doi: 10.1021/bc200606s. Epub 2012 Jul 31.

5.

On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.

Ragupathi G, Coltart DM, Williams LJ, Koide F, Kagan E, Allen J, Harris C, Glunz PW, Livingston PO, Danishefsky SJ.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13699-704. Epub 2002 Oct 1.

6.

Synthetic Approach to Glycopolymer Base Nanoparticle Gold(I) Conjugate: A New Generation of Therapeutic Agents.

Adokoh CK, Darkwa J, Narain R.

Methods Mol Biol. 2016;1367:157-68. doi: 10.1007/978-1-4939-3130-9_13.

PMID:
26537472
7.

Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.

Keding SJ, Danishefsky SJ.

Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):11937-42. Epub 2004 Jul 27.

8.

Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.

Grigalevicius S, Chierici S, Renaudet O, Lo-Man R, Dériaud E, Leclerc C, Dumy P.

Bioconjug Chem. 2005 Sep-Oct;16(5):1149-59.

PMID:
16173792
9.

[Recent advance in carbohydrate-based cancer vaccines].

Huo CX, Ye XS.

Yao Xue Xue Bao. 2012 Mar;47(3):261-70. Review. Chinese.

PMID:
22645748
10.

Thermoresponsive AuNPs Stabilized by Pillararene-Containing Polymers.

Liao X, Guo L, Chang J, Liu S, Xie M, Chen G.

Macromol Rapid Commun. 2015 Aug;36(16):1492-7. doi: 10.1002/marc.201500167. Epub 2015 Jun 1.

PMID:
26033255
12.

Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.

Sungsuwan S, Yin Z, Huang X.

ACS Appl Mater Interfaces. 2015 Aug 12;7(31):17535-44. doi: 10.1021/acsami.5b05497. Epub 2015 Aug 3.

13.

Synthesis and characterisation of glucose-functional glycopolymers and gold nanoparticles: study of their potential interactions with ovine red blood cells.

Wilkins LE, Phillips DJ, Deller RC, Davies GL, Gibson MI.

Carbohydr Res. 2015 Mar 20;405:47-54. doi: 10.1016/j.carres.2014.09.009. Epub 2014 Oct 16.

PMID:
25498199
14.

Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines.

Ojeda R, de Paz JL, Barrientos AG, Martín-Lomas M, Penadés S.

Carbohydr Res. 2007 Feb 26;342(3-4):448-59. Epub 2006 Nov 21.

PMID:
17173881
15.

Constructing an adenocarcinoma vaccine: immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies.

Ragupathi G, Deshpande PP, Coltart DM, Kim HM, Williams LJ, Danishefsky SJ, Livingston PO.

Int J Cancer. 2002 May 10;99(2):207-12.

16.

Gold nanoparticles with a polymerizable surfactant bilayer: synthesis, polymerization, and stability evaluation.

Alkilany AM, Murphy CJ.

Langmuir. 2009 Dec 15;25(24):13874-9. doi: 10.1021/la901270x.

PMID:
20560552
17.

Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience.

Zhu J, Warren JD, Danishefsky SJ.

Expert Rev Vaccines. 2009 Oct;8(10):1399-413. doi: 10.1586/erv.09.95. Review.

18.

Gold Nanoparticles as Carriers for Synthetic Glycoconjugate Vaccines.

Chiodo F, Marradi M.

Methods Mol Biol. 2015;1331:159-71. doi: 10.1007/978-1-4939-2874-3_10.

PMID:
26169740
19.

Immunotherapy for cancer: synthetic carbohydrate-based vaccines.

Buskas T, Thompson P, Boons GJ.

Chem Commun (Camb). 2009 Sep 28;(36):5335-49. doi: 10.1039/b908664c. Epub 2009 Jul 22. Review.

20.

Glycopolymer-Grafted Polymer Particles for Lectin Recognition.

Kohri M, Taniguchi T, Kishikawa K.

Methods Mol Biol. 2016;1367:137-47. doi: 10.1007/978-1-4939-3130-9_11.

PMID:
26537470

Supplemental Content

Support Center